AblationforCardiacArrhythmias near New Haven, CT

Biography: Dr. Elaine Wan is the Esther Aboodi Associate Professor of Medicine in Cardiology and Cardiac Electrophysiology at Columbia University Medical Center, College of Physicians and Surgeons and attending physician at NewYork-Presbyterian Hospital. She is trained in Internal Medicine, Clinical Cardiology and is an invasive cardiac electrophysiologist. She is the Director of Electrophysiology Research and oversees all electrophysiology clinical trials. She performs implantation of cardiac devices including pacemaker and defibrillators, as well as ablation of arrhythmias. Dr. Wan is a physician-scientist and focuses on development of novel treatments for heart failure, vascular dysfunction and arrhythmias such as atrial fibrillation. She is a translational researcher also interested in development of innovative imaging modalities to improve ablation delivery. Dr. Wan is a graduate of the Massachusetts Institute of Technology. She received her medical degree from Columbia University College of Physicians and Surgeons and completed her fellowship in Cardiovascular Diseases and Clinical Cardiac Electrophysiology at NewYork-Presbyterian/Columbia. Dr. Wan is on the Board of Trustees of the Heart Rhythm Society. She is the Chairperson for the NIH Study Section of Imaging Technology Development. She is also the Chairperson-elect for the American Heart Association Committee on Arrhythmia and Electrophysiology. Dr. Wan is the recipient of numerous national and international awards including NIH R01s, R03, K08, the 2016 American College of Cardiology Young Investigator Award First Place in Molecular Cellular Cardiology, 2016 Young Physician Investigator Award from the American Society of Clinical Investigators, 2016 Cardiostim/Europace Best Young EP Presentation (Nice, France) and the 2008 American Heart Association Women in Cardiology for Clinical Excellence.She is the recipient of several competitive research grants including NIH NHLBI K08 Mentored Career Development Award, NIH NHLBI R03 Small Grant Program and NIH NHLBI R01 to study the use of 3D mitochondrial dysfunction imaging in cardiac arrhythmias. She is also a recipient of the American Heart Association Scientist Development Grant, grant support from the Foundation of Gender Specific Medicine, Columbia University Louis V. Gerstner Jr. Scholars Program, and Columbia University Provost's Grants Program for Junior Faculty who Contribute to the Diversity Goals of the University. She is vice co-chair of the Heart Rhythm Society Digital Health Committee and a member of the American Heart Association Committee on Electrocardiography and Arrhythmias. She has published over 100 manuscripts in high impact journals such as Nature Medicine, Circulation, Science Translational Medicine, Circulation Research, Journal of Clinical Investigation and Journal of American College of Cardiology. She has written 3 book chapters and given invited talks around the world.

Biography: Koji Takeda, MD, PhD is a cardiac surgeon and Surgical Director for Adult Heart Transplant at NewYork-Presbyterian/Columbia University Irving Medical Center. Dr. Takeda has a focus on heart failure, heart transplant surgery and mechanical circulatory support through ventricular assist devices (VADs). In addition to his clinical work, he is an active researcher in all of these areas, as well as in cardiac regeneration therapy. Dr. Takeda completed his medical training, post-graduate training, residency and fellowship in Osaka, Japan, after which he completed an advanced cardiovascular surgery fellowship at Northwestern University, Chicago. He is the recipient of multiple honors and awards including the American College of Chest Physicians Award, Japan Branch, 2009; and chief resident award and best resident award, 2005, at the National Cardiovascular Center, Osaka, Japan.

Biography: ColumbiaDoctors Medical Group is one of the largest multi-specialty practices in New York State, comprised of an experienced group of physicians specializing in Cardiology, Vascular Disease, Internal Medicine and Gastroenterology. The physicians at ColumbiaDoctors Medical Group are specialists in many areas of medicine, including: Congenital Heart Failure, Cardiac Transplantation, Cardiovascular Disease, Peripheral Vascular Disease, Pulmonary Hypertension, Arrhythmias, Cardiac Catheterization, Internal Medicine, Gastroenterology, Pulmonary Medicine and Nutrition & Wellness. ColumbiaDoctors Medical Group physicians are faculty members at New York Presbyterian/Columbia University Medical Center and actively participate in advanced research, in an effort to offer patients with complex illnesses access to therapies not readily available elsewhere. Some of the current cardiology protocols include: non-surgical treatments for valvular disease, new treatments for atrial fibrillation, methods to avoid use of blood thinners, as well as modalities to treat blood pressure with less medication. The physicians at ColumbiaDoctors Medical Group practice in several Westchester County locations include Hawthorne, White Plains, Eastchester, Hartsdale, Mount Vernon, Scarsdale, and Somers. Orange County locations include Goshen and Port Jervis New York.

Biography: Giora Weisz, MD, is an Associate Professor in Clinical Medicine at Columbia University Irving Medical Center and serves as the Director of the cardiac Cath Lab at NewYork-Presbyterian Hudson Valley Hospital. He graduated from the Hebrew University-Hadassah Medical School in Jerusalem, Israel, and completed his residency in internal medicine and cardiology fellowship at the Carmel Medical Center in Haifa, Israel. Dr. Weisz finished his interventional cardiology training at Lenox Hill Hospital in New York.As an interventional cardiologist, Dr. Weisz focuses on current and innovative technologies. His expertise includes novel robotic-enhanced coronary interventions, with a special emphasis on navigation and positioning technologies. He also has a keen interest in the management of incomplete revascularization, novel intravascular imaging, and strategies for preventing contrast-induced nephropathy.